Michael Zdanowski

Corporate Officer/Principal at

Medeor Therapeutics, Inc.

59 year

24 connections

Consumer Services

Health Technology

Miscellaneous

Profile

Michael Zdanowski is currently the Vice President-GMP Operations at New York Stem Cell Foundation, Inc. and the Senior VP-Biopharmaceutical Operations at Medeor Therapeutics, Inc. He was previously the Chief Technology Officer at Talaris Therapeutics, Inc. from 2020 to 2023.
He received an undergraduate degree from the University of Pennsylvania and an MBA from Columbia University School of the Arts.

Michael Zdanowski active positions

Companies	Position	Start
Medeor Therapeutics, Inc. Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients	Corporate Officer/Principal	-
New York Stem Cell Foundation, Inc. New York Stem Cell Foundation, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment	Corporate Officer/Principal	-

All active positions of Michael Zdanowski

Former positions of Michael Zdanowski

Companies	Position	End
TOUE BIOPAR	Chief Tech/Sci/R&D Officer	2023-04-27

See the detail of Michael Zdanowski's experience

Training of Michael Zdanowski

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Zdanowski's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New York Stem Cell Foundation, Inc. New York Stem Cell Foundation, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment	Miscellaneous
Columbia University School of the Arts Columbia University School of the Arts Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Medeor Therapeutics, Inc. Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients	Health Technology